Skip to main content
Terug
Watch Compare

JRSIS HEALTH CARE Corp

Datakwaliteit: 100%
JRSS
OTC Services Health Services
€ 0,01
▼ € 0,00 (-26,06%)
Marktkapitalisatie: 837.526,0
Prijs
€ 0,01
Marktkapitalisatie
837.526,0
Dagbereik
€ 0,01 — € 0,01
52-Weeksbereik
€ 0,01 — € 0,10
Volume
70.200
Openen € 0,01
50D / 200D Gem.
€ 0,01
29,29% below
50D / 200D Gem.
€ 0,01
33,56% below

Quick Summary

Belangrijkste Punten

Earnings declined -103,47% over the past year
Negative free cash flow of -244.523,0
Capital efficient — spends only 0,94% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)3782,57%
Earnings (1Y)-103,47%
FCF Growth (3Y)-70,52%

Kwaliteit

Return on Equity
N/A
ROIC-21,42%
Net Margin-3,67%
Op. Margin-7,01%

Veiligheid

Debt / Equity
N/A
Current Ratio0,78
Interest Coverage-3,93

Waardering

PE (TTM)
-4,83
Onder sectorgemiddelde (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -4,8 -1,2
P/B — 1,4
ROE % — -15,7
Net Margin % -3,7 -18,3
Rev Growth 5Y % — 3,8
D/E — 0,4

All Fundamental Metrics
Growth
Revenue Growth (1Y) 3782,57% Revenue Growth (3Y) -72,07%
Earnings Growth (1Y) -103,47% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4,73 M Net Income (TTM) -173.547,0
ROE N/A ROA -8,29%
Gross Margin 15,94% Operating Margin -7,01%
Net Margin -3,67% Free Cash Flow (TTM) -244.523,0
ROIC -21,42% FCF Growth (3Y) -70,52%
Safety
Debt / Equity N/A Current Ratio 0,78
Interest Coverage -3,93 Asset Turnover 2,26
Working Capital -512.474 Tangible Book Value -438.740
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,83 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,18
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -29,20%
Market Cap 837.526,0 Enterprise Value 2,18 M
Per Share
EPS (Diluted TTM) 0,05 Revenue / Share 0,06
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,94% FCF Conversion 140,90%
SBC-Adj. FCF -326.345 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Revenue 3,46 M 89.166,0 44,39 M — —
Net Income -80.912,0 2,33 M 3,19 M 2,68 M 888.061,0
EPS (Diluted) 0,00 -0,75 0,12 0,15 0,05
Gross Profit 483.051,0 — — — —
Operating Income -188.598,0 -325.889,0 4,10 M 5,59 M 4,67 M
EBITDA — — — — —
R&D Expenses 189.266,0 — — — —
SG&A Expenses — — — — —
D&A 53.815,0 5.796,0 — 2,70 M 2,21 M
Interest Expense 56.443,0 — 1,38 M 1,14 M 1,11 M
Income Tax 8.975,0 — 1,18 M 1,37 M 657.699,0

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Total Assets 2,14 M 855.977,0 75,69 M 58,80 M 51,63 M
Total Liabilities 2,31 M 44.661,0 42,59 M 29,96 M 28,64 M
Shareholders' Equity -137.406,0 811.316,0 22,07 M 19,04 M 14,82 M
Total Debt 24.950,0 — — — —
Cash & Equivalents — 58.616,0 855.971,0 844.827,0 1,97 M
Current Assets 1,83 M 798.850,0 13,87 M 7,88 M 9,51 M
Current Liabilities 2,28 M 43.231,0 17,60 M 11,76 M 10,92 M